Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

BACKGROUND: Female sex is an independent risk factor for stroke and systemic embolic events in patients with atrial fibrillation. This study aimed to examine the efficacy and safety profile of edoxaban in women versus men. METHODS: The ENGAGE AF-TIMI 48 trial (Effective Anticoagulation with Factor X...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Circulation
Asıl Yazarlar: Zelniker, Thomas A., Ardissino, Maddalena, Andreotti, Felicita, O’Donoghue, Michelle L., Yin, Ophelia, Park, Jeong-Gun, Murphy, Sabina A., Ruff, Christian T., Lanz, Hans J., Antman, Elliott M., Braunwald, Eugene, Giugliano, Robert P., Merlini, Piera Angelica
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Lippincott Williams & Wilkins 2021
Konular:
Original Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7884089/
https://ncbi.nlm.nih.gov/pubmed/33587659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.120.052216
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller